Ovary Neoplasms
Showing 1 - 25 of 1,703
Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)
Active, not recruiting
- Small Cell Carcinoma, Hypercalcaemic Type
- Ovarian Cancer
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Tumor, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer Trial (AVB-001 (Dose Escalation Phase), AVB-001 (Dose
Not yet recruiting
- Neoplasm, Ovarian
- +7 more
- AVB-001 (Dose Escalation Phase)
- AVB-001 (Dose Expansion Phase)
- (no location specified)
Sep 15, 2022
Cancer of Ovary, Cancer of the Ovary, Tumors, Ovarian Trial in Pittsburgh (Cisplatin + celecoxib + DC vaccine, Cisplatin + CKM +
Suspended
- Cancer of Ovary
- +5 more
- Cisplatin + celecoxib + DC vaccine
- Cisplatin + CKM + Celecoxib + DC Vaccine
-
Pittsburgh, Pennsylvania
- +1 more
Dec 15, 2021
Ovarian Cancer, Tumor, Ovarian, Ovarian Tumor Trial in Xi'an (chemo, targeted therapeutics, immunotherapy, IFRT, IMRT or SBRT)
Recruiting
- Ovarian Cancer
- +16 more
- chemotherapy, targeted therapeutics, immunotherapy
- IFRT, IMRT or SBRT
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Xi'an Jiao Tong University
Sep 25, 2021
Spectroscopy in Ovarian Cancer
Recruiting
- Ovarian Cancer
- +3 more
-
Bristol, United KingdomUniversity Hospitals Bristol and Weston NHS Trust
Oct 4, 2022
Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (FAST Intervention)
Not yet recruiting
- Ovary Cancer
- +2 more
- FAST Intervention
-
Chicago, IllinoisNorthwestern Memorial Hospital
Aug 4, 2023
Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (Fit4Treatment)
Not yet recruiting
- Ovary Cancer
- +6 more
- Fit4Treatment
-
Chicago, IllinoisNorthwestern University
Feb 21, 2023
Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation
Recruiting
- Tumor Recurrence
- +3 more
- carbon ion radiation therapy
-
Pavia, Pv, ItalyCNAO
Jul 13, 2022
Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Recruiting
- Ovarian Neoplasms
- +2 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
Mar 9, 2023
Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)
Not yet recruiting
- Ovary Cancer
- +2 more
- Mirvetuximab Soravtansine
- Olaparib
-
Aurora, ColoradoUniversity of Colorado Hospital
May 30, 2023
Cancer, Breast, Cancer, Uterus, Cancer, Ovary Trial in Miami (With Love, Grandma ("Con Cariño, Abuelita"))
Not yet recruiting
- Cancer, Breast
- +5 more
- With Love, Grandma ("Con Cariño, Abuelita")
-
Miami, FloridaUniversity of Miami
Feb 1, 2023
High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)
Not yet recruiting
- High Grade Serous Adenocarcinoma of Ovary
- +3 more
- (no location specified)
Oct 13, 2023
Tumor Malignant Trial in Napoli (CLG)
Active, not recruiting
- Neoplasm Malignant
- CLG
-
Napoli, Italy
- +1 more
Apr 18, 2023
Ovary Cancer, Stage II-IV, Quality of Life, Depressive Symptoms Trial (POSTCare Survivorship transition process)
Not yet recruiting
- Ovary Cancer, Stage II-IV
- +2 more
- POSTCare Survivorship transition process
- (no location specified)
Feb 22, 2023
Recurrent Ovarian Cancer, Recurrent Epithelial Cancer of Ovary, Recurrent Epithelial Ovarian Cancer Trial in Durham, Oklahoma
Recruiting
- Recurrent Ovarian Cancer
- +6 more
- Oregovomab
- Niraparib
-
Durham, North Carolina
- +2 more
Jul 26, 2022
Gynecologic Cancer, Uterus Cancer, Ovary Cancer Trial in Belfast (Mindfulness and exercise, Mindfulness)
Recruiting
- Gynecologic Cancer
- +5 more
- Mindfulness and exercise
- Mindfulness
-
Belfast, Antrim, United KingdomUlster University
Sep 29, 2022
Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib
Not yet recruiting
- Ovarian Cancer
- +4 more
- Fluzoparib Capsules
- Bevacizumab
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Cetntre
Sep 25, 2023
DKI Combined With APT for Post-treatment Assessment of Ovarian
Not yet recruiting
- Malignant Tumor of the Ovary
- XRCC2 Gene Mutation
- DKI and APT
- (no location specified)
Nov 30, 2022
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)
Not yet recruiting
- Prostate Cancer
- +11 more
- Guided physical exercise
- +2 more
-
Tampere, Länsi-Suomi, FinlandTampere University Hospital
Apr 3, 2023
Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer Trial in Houston (Free genetic testing and counseling group, IGNITE-TX
Not yet recruiting
- Gynecologic Cancer
- +8 more
- Free genetic testing and counseling group
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Jan 11, 2023
Ovarian Cancer, Breast Cancer Trial in Dallas (Lynparza)
Active, not recruiting
- Ovarian Cancer
- Breast Cancer
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Mar 22, 2022